RACE-2L: Real-World Assessment of Clinical Practice and Outcomes in Non-squamous Non-Small Cell Lung Cancer after failure of platinum-based chemotherapy in Brazil

Trial Identifier:	D133HR00041
Sponsor:	AstraZeneca
Start Date:	June 2024
Primary Completion Date:	March 2025
Study Completion Date:	March 2025
Condition:	Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.